Does WARFARIN Cause Product formulation issue? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product formulation issue have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.0% of all adverse event reports for WARFARIN.
6
Reports of Product formulation issue with WARFARIN
0.0%
of all WARFARIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product formulation issue From WARFARIN?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Product formulation issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Product formulation issue?
MINOXIDIL (1,369)
LEVOTHYROXINE (740)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174)
OMEPRAZOLE (99)
METHYLPHENIDATE (78)
OXYCODONE (73)
ACETAMINOPHEN\HYDROCODONE (62)
ACETAMINOPHEN\OXYCODONE (61)
ACETAMINOPHEN (59)
BUPROPION (59)